Recent News

Author: admin

Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s.

Top 10 Gold ETFs in 2025

adminNovember 19, 20250
Gold exchange-traded funds, or gold ETFs, have risen in popularity among investors who want precious metals exposure. ETFs are similar to mutual funds in that they track assets such as stocks, bonds, currencies or commodities; a key difference is that ETFs can be bought and sold on exchanges, making them widely accessible. They provide considerable […]
Read more

Hydrogeological Testing Underway at Lo Herma

adminNovember 19, 20250
American Uranium Limited (ASX:AMU, OTC:AMUIF) (American Uranium, AMU or the Company) is pleased to advise that hydrogeological testing at its Lo Herma ISR uranium project in Wyoming’s Powder River Basin has commenced. Testing is being undertaken by Petrotek Corporation, a leading injection well and subsurface resources consultancy with more than 28 years of experience in […]
Read more

Prismo Develops Additional Drill Targets at Silver King Provides Update on Drill Permit

adminNovember 19, 20250
(TheNewswire) Vancouver, British Columbia, November 19, 2025 TheNewswire – Prismo Metals Inc. (the ‘ Company ‘) (CSE: PRIZ,OTC:PMOMF) (OTCQB: PMOMF) is pleased to report that it has completed a detailed exploration program at the Black Diamond area of its Silver King Project located in Arizona. Work consisted of mapping and sampling of the area including […]
Read more

Is the AI Arms Race Bolstering Demand for Gold?

adminNovember 18, 20250
The gold price has been trading at record highs above US$4,000 per ounce since October. As top tech companies like NVIDIA (NASDAQ:NVDA), Microsoft (NASDAQ:MSFT) and Alphabet (NASDAQ:GOOGL) battle for AI supremacy, investors are wondering if this arms race is boosting the rush to gold. Gold is an essential material in sophisticated computer infrastructure, sparking headlines […]
Read more

InMed Pharmaceuticals

adminNovember 18, 20250
Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a revenue-generating manufacturing subsidiary. The company is an undervalued opportunity with cash exceeding market capitalization and multiple upcoming catalysts. Overview InMed Pharmaceuticals (NASDAQ:INM) is a biopharmaceutical company with a differentiated business model: advancing innovative therapeutic programs […]
Read more
1 … 22 23 24 25 26 … 182

Grid News

Latest Post

Copyright © 2025 thegoldencapital.ca. All Right Reserved.